ImmunityBio, Inc. (IBRX)
NASDAQ · Healthcare
ImmunityBio, Inc. Gross Profit 2013–2025
ImmunityBio, Inc. annual/quarterly gross profit history and growth rate from 2022 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- ImmunityBio, Inc. gross profit for the quarter ending March 31, 2026 was 44.0 M, a 167.14% increase year-over-year.
- ImmunityBio, Inc. gross profit for the twelve months ending March 31, 2026 was 118.6 M, a 1530.24% increase year-over-year.
- ImmunityBio, Inc. annual gross profit for 2025 was 112.5 M, a 663.21% increase from 2024.
- ImmunityBio, Inc. annual gross profit for 2024 was 14.7 M, a 2270.58% increase from 2023.
- ImmunityBio, Inc. annual gross profit for 2023 was 622000, a 159.17% increase from 2022.
- ImmunityBio, Inc. annual gross profit for 2022 was 240000.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
ImmunityBio, Inc. Gross Profit — FAQ
ImmunityBio, Inc. (IBRX) gross profit over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
What is ImmunityBio, Inc.'s gross profit?
ImmunityBio, Inc. (IBRX) reported gross profit of $113M for fiscal 2025.
Where can I see IBRX's gross profit history?
The chart and table above show ImmunityBio, Inc.'s gross profit by year and by quarter, including the growth rate.